DK387387D0 - PURIFIED FOSTER-THYMIDINE Kinase AND PROCEDURES FOR PREPARING IT AND ITS USE - Google Patents

PURIFIED FOSTER-THYMIDINE Kinase AND PROCEDURES FOR PREPARING IT AND ITS USE

Info

Publication number
DK387387D0
DK387387D0 DK387387A DK387387A DK387387D0 DK 387387 D0 DK387387 D0 DK 387387D0 DK 387387 A DK387387 A DK 387387A DK 387387 A DK387387 A DK 387387A DK 387387 D0 DK387387 D0 DK 387387D0
Authority
DK
Denmark
Prior art keywords
purified
preparing
thymidine kinase
foster
procedures
Prior art date
Application number
DK387387A
Other languages
Danish (da)
Other versions
DK387387A (en
Inventor
Pierre Nicolas Jouan
Original Assignee
Debat Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debat Lab filed Critical Debat Lab
Publication of DK387387D0 publication Critical patent/DK387387D0/en
Publication of DK387387A publication Critical patent/DK387387A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to purified thymidine kinase of foetal type (abbreviated to TK-F) as a new industrial product. It also relates to the process for preparing the purified TK-F by a process which comprises coupling the TK-F with thymidine and then cleaving the resulting TK-F-thymidine complex. The purified TK-F according to the invention can be used in the preparation of antiTK-F antibody to be involved especially as a reagent in the field of dosages and as a medication in therapeutics.
DK387387A 1986-07-31 1987-07-24 PURIFIED FOSTER-THYMIDINE Kinase AND PROCEDURES FOR PREPARING IT AND ITS USE DK387387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611101A FR2602242B1 (en) 1986-07-31 1986-07-31 THYMIDINE KINASE PURIFIED FETAL TYPE

Publications (2)

Publication Number Publication Date
DK387387D0 true DK387387D0 (en) 1987-07-24
DK387387A DK387387A (en) 1988-02-01

Family

ID=9337917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK387387A DK387387A (en) 1986-07-31 1987-07-24 PURIFIED FOSTER-THYMIDINE Kinase AND PROCEDURES FOR PREPARING IT AND ITS USE

Country Status (14)

Country Link
EP (1) EP0255431B1 (en)
JP (1) JPS6359886A (en)
CN (1) CN87105215A (en)
AT (1) ATE68821T1 (en)
AU (1) AU594486B2 (en)
DE (1) DE3774025D1 (en)
DK (1) DK387387A (en)
ES (1) ES2038681T3 (en)
FR (1) FR2602242B1 (en)
GR (1) GR3003416T3 (en)
IE (1) IE61237B1 (en)
NZ (1) NZ221246A (en)
PT (1) PT85406B (en)
ZA (1) ZA875378B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785993B1 (en) * 1993-08-06 2003-05-07 Brigham Young University Technology Transfer Office Monoclonal antibodies to thymidine kinase isozymes
SE9401380D0 (en) * 1994-04-22 1994-04-22 Sven Skog New cell growth-related peptide and its use
CN1301821A (en) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 New polypeptide-thymidylate kinase 11 and polynucleotide coding such polypeptide
US7311906B2 (en) 2004-04-30 2007-12-25 Brigham Young University Anti-viral activity of an anti-thymidine kinase monoclonal antibody
US8551486B2 (en) 2004-05-21 2013-10-08 Savoy Pharmaceuticals, Inc. Monoclonal antibodies to human thymidine kinase to treat cancer
US7837998B2 (en) 2004-05-21 2010-11-23 Nathaniel Lallatin Anti-cancer activity of an anti-thymidine kinase monoclonal antibody
WO2011082345A2 (en) 2009-12-30 2011-07-07 Brigham Young University Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2028588A1 (en) * 1970-06-10 1971-12-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Method of Obtaining Thymidine Kinase

Also Published As

Publication number Publication date
ZA875378B (en) 1988-01-29
CN87105215A (en) 1988-02-24
GR3003416T3 (en) 1993-02-17
AU594486B2 (en) 1990-03-08
NZ221246A (en) 1991-05-28
IE872064L (en) 1988-01-31
ATE68821T1 (en) 1991-11-15
PT85406B (en) 1990-04-30
JPH0438392B2 (en) 1992-06-24
ES2038681T3 (en) 1993-08-01
EP0255431B1 (en) 1991-10-23
AU7607587A (en) 1988-02-04
FR2602242A1 (en) 1988-02-05
JPS6359886A (en) 1988-03-15
EP0255431A1 (en) 1988-02-03
IE61237B1 (en) 1994-10-19
FR2602242B1 (en) 1989-05-26
DE3774025D1 (en) 1991-11-28
PT85406A (en) 1987-08-01
DK387387A (en) 1988-02-01

Similar Documents

Publication Publication Date Title
FI96204C (en) Process for the preparation of therapeutically useful heterocyclic compounds
NO175601C (en) Liquid, enzyme-containing mixture, as well as process for its preparation
DE69434532D1 (en) Process for the preparation of a high trehalose content product
DE69031791D1 (en) Process for HCV cultivation in cell lines from B or T lymphocytes
ES8304068A1 (en) Modified d-retro cyclic hexapeptide somatostatin analogs, process for their preparation and pharmaceutical compositions containing them.
DK387387D0 (en) PURIFIED FOSTER-THYMIDINE Kinase AND PROCEDURES FOR PREPARING IT AND ITS USE
EP0192988A3 (en) Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
DE68916754D1 (en) Process for the production of optically active 3-hydroxybutyric acid.
IT8621312A0 (en) PROCESS OF (CO)POLYMERIZATIONS OF ALPHA OLEFINS IN THE PRESENT OF STABILIZERS.
DE3851618D1 (en) Process for the preparation of alkylarsine compounds.
PT75548B (en) Process for preparing beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
NO882255L (en) PROCEDURE FOR THE PREPARATION OF OLEFIN-MALEIC ACID ANHYRIDE COPOLYMES IN THE FORM OF PARTICLES.
DE58908276D1 (en) Process for the oligomerization of hexafluoropropene oxide.
Naveh et al. Large scale downstream processing of monoclonal antibodies.
DE69319358D1 (en) Process for the preparation of alkylarsine compounds
DK628188A (en) PROTEIN AND PROCEDURE FOR PREPARING THEREOF
IT1198402B (en) POLYPRENYL COMPOUNDS, PROCESS FOR THE PRODUCTION OF THE SAME AND MEDICINES CONTAINING THE SAME
IT210806Z2 (en) HANDLING DEVICE TO BE USED IN MACHINES FOR THE PRODUCTION OF GLASSWARE ITEMS.
DE3851942D1 (en) Process for the production of optically active alpha-isopropyl-p-chlorophenylacetic acid.
ATE105570T1 (en) MODIFIED HUMAN ANTI-RH(D) ANTIBODIES.
Berg Some in vitro studies of inhibitors of rat brain acetylcholinesterase
IT8120398A0 (en) EQUIPMENT FOR CARRYING OUT CONDENSATION REACTIONS IN THE LIQUID PHASE AND PROCESS FOR THE PRODUCTION OF TRIMETHYL BORATE USING THE SAME.
DE3885044D1 (en) Etching process for metal objects made of zirconium.
Durieux et al. Solid phase synthesis of gastrin and CCK-PZ fragments
IT8802104A0 (en) IMPROVED PROCESS FOR THE PRODUCTION OF MIXTURES OF SOLIDS IN LIQUIDS WITH HIGH SOLIDS CONCENTRATION

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment